In summary, these results suggested that LMO2 was positively associated with some metabolism pathways in normal breast tissue, negatively associated with some cancer-related pathways, such as stemness regulation, ErbB pathway, Estrogen pathway and central carbon metabolism in malignant breast tissue, and associated with many dual-directional functions in both normal and malignant breast tissues. This evidence concerns the gene EGFR and cancer.